Be Ahead With Economy And Policy Updates
New Jersey: Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch1 of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial.
Hyderabad: Dr. Reddy’s Laboratories today announced the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif®, in the United States, expanding
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for
Mumbai: India Ratings and Research (Ind-Ra) believes Indian pharma companies’ strong balance sheets and sub-1x leverage profile (FY26: nearly 0.8x) provide headroom for
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for
New Jersey: Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the launch1 of Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials.
Gurugram: Antara, India’s most comprehensive senior care ecosystem offering end-to-end solutions across all stages of ageing, has opened an integrative medicine clinic in Gurugram,
Hyderabad, India: NATCO Pharma Limited (BSE: 524816 and NSE: NATCOPHARM) (“NATCO”) and its alliance partner Lupin Limited today announced the approval from the
Hyderabad, India: Granules India Limited announced that its wholly-owned subsidiary on Wednesday, Granules Pharmaceuticals, Inc. (GPI), located in Chantilly, Virginia, US, has received the
Raichur, India: Shilpa Biocare Pvt Ltd, a wholly owned subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED), a global innovative pharma company and CDMO, today
Newsletter
Tata Motors announces price increase for commercial vehicles from July 2026
BCCL Hands Over Dugda Coal Washery to JSW for Coal Sector Monetization
Nykaa Targets USD 5 Billion GMV Beauty and Lifestyle Business by FY30